Richardson Healthcare is a medical device company committed to creating value through innovation. We develop high-performance, cost-effective and sustainable solutions that support best practice and improve the lives of patients.

Journal of Wound Care (JWC) is the peer-reviewed, international wound care title, publishing the latest research and clinical expertise for practitioners. PubMed-listed with an Impact Factor, it is an official partner of the European Wound Management Association (EWMA) and the World Union of Wound Healing Societies (WUWHS) – testament to its quality and relevance worldwide.

Published monthly, and with more than 14,000 pages of content in our online archive, the range of information JWC offers is unmatched anywhere. The journal supports the educational development of wound care professionals by providing a trusted evidence base to inform advanced knowledge and skills.

Why choose us?

Quality - articles are peer-reviewed and based on the best available evidence
Quantity - with 3,000+ articles, JWC is the world's leading source of wound care information
Comprehensive - extensive coverage on everything from biofilm and burns to pressure ulcers
Relevant - JWC is written by your fellow professionals, and designed for its application to practice

Haddenham Healthcare is a company specializing in the treatment of lymphoedema and chronic oedema. Our focus is on providing problem solving solutions to assist therapists in treating their patients - helping them achieve clinical effectiveness and patient compliance. Haddenham have a wide range of innovative and unique products available on Drug Tariff – including the unique and UK patented Easywrap compression wrap and Microfine toecaps.

Founded in 2011 by CEO John Ruprai, Ennogen is a licensed wholesaler and distributor of pharmaceuticals and medical devices to the UK and Europe as well as many countries in Asia, Africa and the Middle East. Since it was established, Ennogen has developed a differentiated portfolio of over 150 Market Authorisations, holds the ISO13485 accreditation and is the legal manufacturer and distributor of a range of medical devices including various barrier ointments, creams, soap substitutes and products to alleviate dry mouth conditions.
Email: info@ennogen.com

Biocomposites is an international medical device company that engineers, manufactures and markets world-leading products for use in infection management in bone and soft tissue. Based in Keele, UK, it has global operations across Europe, USA, Canada, China and India. Biocomposites is a world leader in the development of innovative calcium compounds for surgical use. Its products target a broad spectrum of infection risks across a variety of specialities, including musculoskeletal infection, orthopaedics, trauma, spine, foot and ankle and podiatry.